Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal announces acquisition of specialist formulation company Formulytica

Opal announces acquisition of specialist formulation company Formulytica May 5, 2021 • Category • Author Name

Opal announces acquisition of specialist formulation company Formulytica

Latest News

2022 BioDiem AGM

December 21, 2022

BioDiem 2022 AGM Results of AGM CEO Presentation Chairman’s Address

Read More
2022 BioDiem Annual Report

November 25, 2022

View the Annual Report

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions